# CYP17A1

## Overview
CYP17A1 is a gene that encodes the enzyme cytochrome P450 family 17 subfamily A member 1, a critical component of the cytochrome P450 superfamily. This enzyme is primarily involved in steroidogenesis, facilitating the conversion of pregnenolone and progesterone into their 17α-hydroxylated derivatives and subsequently into androgens and estrogens. The CYP17A1 protein is characterized by its heme-binding domain, which is essential for its enzymatic activity, and is predominantly α-helical in structure. It is located in the endoplasmic reticulum of cells, where it plays a vital role in the synthesis of glucocorticoids and sex steroids. The enzyme's activity is modulated by interactions with other proteins, such as cytochrome b5 and cytochrome P450 reductase, which influence its catalytic efficiency. Mutations in the CYP17A1 gene can lead to congenital adrenal hyperplasia, affecting steroid hormone synthesis and resulting in various clinical manifestations (Locke2009A; Xia2021Novel; Yadav2017Structural).

## Structure
The CYP17A1 protein is a member of the cytochrome P450 superfamily, characterized by a heme prosthetic group in its active site, which is crucial for its enzymatic activity (Yadav2017Structural). The protein's structure is predominantly α-helical, comprising twelve major helices and a few minor ones, contributing to its overall stability and function (Yadav2017Structural). The active site of CYP17A1 is notable for its interaction with substrates, where the C3 hydroxyl of inhibitors forms a hydrogen bond with the side chain of Asn202 in helix F, suggesting a similar binding mode for steroidal substrates (Yadav2017Structural).

CYP17A1's tertiary structure is a compact, globular form with a heme-binding domain, which is typical of cytochrome P450 enzymes. This structure allows for the displacement of water upon substrate binding, leading to spectral shifts that help identify binding modes (Yadav2017Structural). The enzyme's function is modulated by cytochrome b5, which influences its lyase activity (Yadav2017Structural).

The protein may undergo post-translational modifications, such as phosphorylation, which can affect its activity and interactions. CYP17A1 also exists in different isoforms due to alternative splicing, which may result in variations in its functional properties.

## Function
CYP17A1, a member of the cytochrome P450 enzyme family, plays a crucial role in steroidogenesis, primarily in the adrenal glands and gonads. It catalyzes two key reactions: 17α-hydroxylation and 17,20-lyase activity. These reactions are essential for the conversion of C-21 steroids, such as pregnenolone and progesterone, into their 17α-hydroxylated derivatives and subsequently into C-19 steroids like dehydroepiandrosterone (DHEA) and androstenedione (Locke2009A). These C-19 steroids serve as precursors for the synthesis of androgens and estrogens, which are vital for various physiological processes, including the development and maintenance of secondary sexual characteristics and reproductive function.

CYP17A1 is active in the endoplasmic reticulum of cells, where it facilitates the production of glucocorticoids and sex steroids, influencing hormone synthesis and regulation (Emanuelsson2018Expression). The enzyme's activity is not only crucial for normal endocrine function but also plays a role in the local synthesis of androgens within tissues, which can be significant in certain pathological conditions, such as castration-resistant prostate cancer (Locke2009A). The regulation of CYP17A1 expression and activity is complex and can be influenced by factors such as vitamin D, which has been shown to suppress its mRNA expression in certain cell types (Emanuelsson2018Expression).

## Clinical Significance
Mutations in the CYP17A1 gene can lead to 17α-hydroxylase/17,20-lyase deficiency, a rare form of congenital adrenal hyperplasia (CAH). This condition is characterized by impaired steroid hormone synthesis, resulting in cortisol deficiency, overproduction of ACTH, adrenal hyperplasia, and excessive synthesis of mineralocorticoid precursors. Clinically, this can manifest as low-renin hypertension and hypokalemia. In terms of sexual development, affected individuals may experience a lack of pubertal development, with males potentially having undermasculinized external genitalia and females experiencing primary amenorrhea (Xia2021Novel).

In Chinese patients, novel mutations such as c.887T>C (p.I296T), c.1019G>A (p.R340H), and c.1346G>A (p.R449H) have been identified, with some affecting the enzyme's structure and function, leading to partial 17α-hydroxylase/17,20-lyase deficiency. These mutations are associated with symptoms like irregular menstruation, spontaneous breast development, and recurrent ovarian cysts (Xia2021Novel).

In Brazilian populations, prevalent mutations such as W406R and R362C account for a significant portion of 17-hydroxylase deficiency cases. These mutations are linked to phenotypic variations, including hypertension, hypokalemia, and sexual infantilism, and are thought to result from founder effects in certain regions (CostaSantos2004Two).

## Interactions
CYP17A1 interacts with several proteins that influence its enzymatic activity. One significant interaction is with cytochrome b5, which modulates the enzyme's lyase activity. Cytochrome b5 is proposed to enhance CYP17A1 activity through two main mechanisms: direct electron transfer and facilitating a conformational change that favors the lyase reaction. However, cytochrome b5 does not significantly alter the binding kinetics of substrates like 17α-OH pregnenolone or 17α-OH progesterone, as no changes in dissociation constants were observed in its presence (Guengerich2019Conformational).

CYP17A1 also interacts with cytochrome P450 reductase, which is essential for electron transfer during the enzyme's catalytic cycle. This interaction is crucial for the hydroxylation and lyase reactions that CYP17A1 catalyzes in steroidogenesis. The enzyme's activity and interactions are further influenced by the presence of specific ligands, which can induce conformational changes and affect the geometry and dynamics of tunnels within the protein structure. These tunnels are pathways that connect the ligand-binding site to the protein surface, and their formation is modulated by ligand binding, impacting the enzyme's function and interactions (Xiao2020Comparative).


## References


[1. (Locke2009A) Jennifer A. Locke, Ladan Fazli, Hans Adomat, Jil Smyl, Kristin Weins, Amy A. Lubik, Dale B. Hales, Colleen C. Nelson, Martin E. Gleave, and Emma S. Tomlinson Guns. A novel communication role for cyp17a1 in the progression of castration‐resistant prostate cancer. The Prostate, 69(9):928–937, March 2009. URL: http://dx.doi.org/10.1002/pros.20940, doi:10.1002/pros.20940. This article has 30 citations.](https://doi.org/10.1002/pros.20940)

[2. (CostaSantos2004Two) Marivânia Costa-Santos, Claudio E. Kater, and Richard J. Auchus. Two prevalentcyp17mutations and genotype-phenotype correlations in 24 brazilian patients with 17-hydroxylase deficiency. The Journal of Clinical Endocrinology &amp; Metabolism, 89(1):49–60, January 2004. URL: http://dx.doi.org/10.1210/jc.2003-031021, doi:10.1210/jc.2003-031021. This article has 174 citations.](https://doi.org/10.1210/jc.2003-031021)

[3. (Guengerich2019Conformational) F. Peter Guengerich, Clayton J. Wilkey, Sarah M. Glass, and Michael J. Reddish. Conformational selection dominates binding of steroids to human cytochrome p450 17a1. Journal of Biological Chemistry, 294(26):10028–10041, June 2019. URL: http://dx.doi.org/10.1074/jbc.ra119.008860, doi:10.1074/jbc.ra119.008860. This article has 35 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra119.008860)

[4. (Xiao2020Comparative) Fei Xiao, Xingyu Song, Peiyi Tian, Mi Gan, Gennady M. Verkhivker, and Guang Hu. Comparative dynamics and functional mechanisms of the cyp17a1 tunnels regulated by ligand binding. Journal of Chemical Information and Modeling, 60(7):3632–3647, June 2020. URL: http://dx.doi.org/10.1021/acs.jcim.0c00447, doi:10.1021/acs.jcim.0c00447. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.jcim.0c00447)

[5. (Emanuelsson2018Expression) Ida Emanuelsson, Mokhtar Almokhtar, Kjell Wikvall, Alfhild Grönbladh, Erik Nylander, Anne-Lie Svensson, Åsa Fex Svenningsen, and Maria Norlin. Expression and regulation of cyp17a1 and 3β-hydroxysteroid dehydrogenase in cells of the nervous system: potential effects of vitamin d on brain steroidogenesis. Neurochemistry International, 113:46–55, February 2018. URL: http://dx.doi.org/10.1016/j.neuint.2017.11.007, doi:10.1016/j.neuint.2017.11.007. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.neuint.2017.11.007)

[6. (Xia2021Novel) Yanjie Xia, Panlai Shi, Junke Xia, Huijuan Zhang, Lijun Xu, and Xiangdong Kong. Novel mutations of the cyp17a1 gene in four chinese 46,xx cases with partial 17a-hydroxylase/17,20-lyase deficiency. Steroids, 173:108873, September 2021. URL: http://dx.doi.org/10.1016/j.steroids.2021.108873, doi:10.1016/j.steroids.2021.108873. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.steroids.2021.108873)

[7. (Yadav2017Structural) Rahul Yadav, Elyse M. Petrunak, D. Fernando Estrada, and Emily E. Scott. Structural insights into the function of steroidogenic cytochrome p450 17a1. Molecular and Cellular Endocrinology, 441:68–75, February 2017. URL: http://dx.doi.org/10.1016/j.mce.2016.08.035, doi:10.1016/j.mce.2016.08.035. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mce.2016.08.035)